LIGAND PHARMACEUTICALS INC (LGND) › Total LiabilitiesLIGAND PHARMACEUTICALS INC (LGND) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $72.06M2011: $104.05M2012: $77.78M2013: $55.10M2014: $233.62M2015: $226.15M2016: $230.73M2017: $252.37M2018: $699.89M2019: $727.68M2020: $652.76M2021: $476.43M2022: $165.18M2023: $86.30M2024: $111.33M2025: $543.42M$543.42M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$543.42M+388.1%2024$111.33M+29.0%2023$86.30M-47.8%2022$165.18M-65.3%2021$476.43M-27.0%2020$652.76M-10.3%2019$727.68M+4.0%2018$699.89M+177.3%2017$252.37M+9.4%2016$230.73M+2.0%2015$226.15M-3.2%2014$233.62M+324.0%2013$55.10M-29.2%2012$77.78M-25.3%2011$104.05M+44.4%2010$72.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share